Squarepoint Ops LLC Hepion Pharmaceuticals, Inc. Transaction History

Squarepoint Ops LLC

  • $62.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$1.77 - $2.98 $198,201 - $333,694
-111,978 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$1.58 - $3.64 $152,397 - $351,092
96,454 Added 621.32%
111,978 $245,000
Q3 2020

Nov 16, 2020
BUY
$2.84 - $4.59 $7,506 - $12,131
2,643 Added 20.52%
15,524 $48,000
Q2 2020

Aug 14, 2020
BUY
$1.31 - $3.09 $16,874 - $39,802
12,881 New
12,881 $37,000

About Hepion Pharmaceuticals, Inc.

HEPA Quotes by TradingView
  • Ticker HEPA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,229,600
  • Market Cap $49.5M
  • Description
  • Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver...
More about HEPA
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email